The U.S. Viral Vector CDMO Market is projected to reach USD 2.75 Billion by 2035, while Europe is expected to reach USD 1.93 Billion.Austin, United States, Aug. 18, 2026 (GLOBE NEWSWIRE) -- The Viral ...
The viral vector CDMO market is witnessing robust growth, fueled by the rapid expansion of gene and cell therapy development and the increasing number of clinical trials worldwide. Rising demand for ...
Explore strategies for improving recombinant adeno-associated virus production in transient HEK293 suspension cultures while maintaining vector quality and supporting scalable viral vector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results